Professor Mitchell completed a PhD in Pharmacology with Sir Professor John R Vane (FRS, Nobel Laureate) and Dr Gilberto De Nucci 1990 before joining Professor Ferid Murad (NAS USA, Nobel Laureate) as a fellow of Northwestern University (Chicago, USA) for her postdoctoral training in the biochemistry of nitric oxide synthase. She returned to work with John Vane on the pharmacology of cyclo-oxygenase isoforms before joining the group of Professor Timothy Williams at the National Heart and Lung Institute, now part of Imperial College.
Professor Mitchell was awarded a Wellcome Trust Career Development Fellowship in 1997 and the Novartis Prize for Pharmacology in 1999 for her contribution to the field of cyclo-oxygeanse biology. Since this time, Professor Mitchell has led her own group - Cardiothoracic Pharmacology - consisting of academics, clinicians, postdoctoral fellows and undergraduate/postgraduate students.
Professor Mitchell is amongst the top 1% of cited pharmacologists world-wide and as such, is a member of Thomson Scientific Highlycited listings (isihighlycited.com) with more than 150 publications in peer reviewed journals.
Professor Mitchell was awarded the 2009 Rector’s Award for Excellence in Research Supervision and Elected Research Supervision Fellow.
Professor Mitchell was awarded the AstraZeneca Women in Pharmacology Prize in 2012. She talks about receiving the award here.
Mitchell J, Bishop-Bailey D, PPARβ/δ a potential target in pulmonary hypertension blighted by cancer risk., Pulmonary Circulation, ISSN:2045-8940
et al., 2018, Preventing bronchopulmonary dysplasia: new tools for an old challenge., Pediatr Res
Mitchell JA, Bishop-Bailey D, 2018, EXPRESS: PPARβ/δ a potential target in pulmonary hypertension blighted by cancer risk., Pulm Circ, ISSN:2045-8932
et al., 2018, Development of a novel UHPLC-MS/MS-based platform to quantify amines, amino acids and methylarginines for applications in human disease phenotyping, Scientific Reports, Vol:8, ISSN:2045-2322
et al., 2018, Development of a human autologous 3-cell cytokine release assay that models the vascular wall in vitro, 54th Congress of the European-Societies-of-Toxicology (EUROTOX) - Toxicology Out of the Box, ELSEVIER IRELAND LTD, Pages:S114-S114, ISSN:0378-4274